跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 36 条关于
“SureTAC”
全部
36
临床试验
1
药物
21
机构
2
资讯
12
9个月前
Laigo Bio Secures €11.5 Million to Advance Novel Protein Degradation Platform for Cancer and Autoimmune Diseases
8个月前
Enodia Therapeutics Secures €20.7M Seed Funding to Advance Novel Protein Degradation Platform Targeting SEC61 Translocon
5个月前
Laigo Bio Secures €17M in Oversubscribed Seed Round to Advance Novel Protein Degradation Platform
11个月前
BioNTech Secures German Regulatory Approval for $1.25 Billion CureVac Acquisition
2年前
GSK and CureVac Announce Positive Phase 2 Data for mRNA Seasonal Influenza Vaccine
10个月前
CureVac Reports €371.6 Million Net Income Following GSK Partnership and Strategic Restructuring
9个月前
BioNTech Completes CureVac Acquisition with 81.74% Shareholder Acceptance, Consolidating mRNA Technology Portfolio
去年
CureVac Wins Key Patent Validity Decision in Ongoing mRNA Litigation Against BioNTech
去年
BioNTech to Acquire CureVac for $1.25 Billion to Strengthen mRNA Cancer Immunotherapy Pipeline
2个月前
Moderna Files Countersuit Against CureVac in Ongoing COVID-19 mRNA Vaccine Patent Dispute
第 1 页,共 2 页
上一页
下一页